Kristen Cardinal

Kristen Cardinal

Works at:

RIKEN Brain Science Institute

Location in:

Japan, Japan

Kristen Cardinal

Kristens connections

Currently

Works at:
RIKEN Brain Science Institute
Location in:
Japan, Japan

Bio

A dynamic, self-directed professional with demonstrated excellence in translating science into strategy. Experienced in the successful launch of products and teams in diverse markets, with a special interest in innovation and exploring new business models.

Kristen has worked/studied in

  • Japan
  • Switzerland
  • United Kingdom
  • United States of America

Kristen speaks

  • French
  • German
  • Italian
  • Japanese

Join or Login to view the full profile

Only members of BusinessBecause can view full member profiles. Joining only takes one minute and you can sign in with your LinkedIn account...

Create a profile...


Work

2013 – present

Director of Global Development

RIKEN Brain Science Institute
  • Business development, collaborations, partnerships, and outreach.
2012 – present

Trustee

Metro Centre (Charity)
  • Served on Board of Trustees to manage strategic decisions and planning for the charity.
2012 – 2013
(Jan – Jul)

Medical Director, Europe, PET Neurology

GE Energy
  • *Responsible for the development and execution of the EMEA Medical Affairs strategy in PET Neurology
  • *Provision of scientific leadership and participation at scientific meetings and presentation of key clinical evidence to referral groups and Key Opinion Leaders
  • *Review and approval of promotional materials
  • *Assessment of investigator initiated trials and educational grants as well as collaboration with central R&D providing feedback to the development plans
2011
(Sep – Nov)

First Place Winner - GSK Competition for Sustainable Business Models in Rare Diseases

GlaxoSmithKline (GSK)
  • Competition details and winning report available at:
  • http://www.gsk.com/rare-diseases/
2011
(Sep – Nov)

Project Consultant - CEO's Future Strategy Group, Disruptive Technologies

GlaxoSmithKline (GSK)
  • Developed a report on disruptive innovation in the pharmaceutical industry with recommendations for strategy.
2009 – 2011

Global Medical Science Liaison Manager

Actelion
  • Based in London, UK.
  • Development and execution of medical strategy for the UK, Netherlands, Nordics, and Portugal and engagement with leading experts in research and medicine.
  • Therapeutic area: Rare Diseases, metabolic disorders, neurology
2008 – 2009
(Aug – Jul)

Senior Scientific Advisor - Team Manager

Abbott Laboratories
  • Based in London, UK.
  • Responsible for the creation and successful launch of Abbott UK’s first field-based Scientific Advisor team for its flagship product.
2006 – 2008

Medical Science Liaison/Clinical Science Manager

Abbott Laboratories
  • Based in San Francisco, CA.
2005 – 2006
(Mar – May)

Postdoctoral research fellow

UCLA
1999 – 2003

PhD Student

Institute of Neuroinformatics- Uni/ETH Zurich

Work

2013 – present

Director of Global Development

RIKEN Brain Science Institute
  • Business development, collaborations, partnerships, and outreach.
2012 – present

Trustee

Metro Centre (Charity)
  • Served on Board of Trustees to manage strategic decisions and planning for the charity.
2012 – 2013
(Jan – Jul)

Medical Director, Europe, PET Neurology

GE Energy
  • *Responsible for the development and execution of the EMEA Medical Affairs strategy in PET Neurology
  • *Provision of scientific leadership and participation at scientific meetings and presentation of key clinical evidence to referral groups and Key Opinion Leaders
  • *Review and approval of promotional materials
  • *Assessment of investigator initiated trials and educational grants as well as collaboration with central R&D providing feedback to the development plans
2011
(Sep – Nov)

First Place Winner - GSK Competition for Sustainable Business Models in Rare Diseases

GlaxoSmithKline (GSK)
  • Competition details and winning report available at:
  • http://www.gsk.com/rare-diseases/
2011
(Sep – Nov)

Project Consultant - CEO's Future Strategy Group, Disruptive Technologies

GlaxoSmithKline (GSK)
  • Developed a report on disruptive innovation in the pharmaceutical industry with recommendations for strategy.
2009 – 2011

Global Medical Science Liaison Manager

Actelion
  • Based in London, UK.
  • Development and execution of medical strategy for the UK, Netherlands, Nordics, and Portugal and engagement with leading experts in research and medicine.
  • Therapeutic area: Rare Diseases, metabolic disorders, neurology
2008 – 2009
(Aug – Jul)

Senior Scientific Advisor - Team Manager

Abbott Laboratories
  • Based in London, UK.
  • Responsible for the creation and successful launch of Abbott UK’s first field-based Scientific Advisor team for its flagship product.
2006 – 2008

Medical Science Liaison/Clinical Science Manager

Abbott Laboratories
  • Based in San Francisco, CA.
2005 – 2006
(Mar – May)

Postdoctoral research fellow

UCLA
1999 – 2003

PhD Student

Institute of Neuroinformatics- Uni/ETH Zurich

Additional Info

Website
blog.students.london.edu/author/kristen
Nationality:
  • American